Fundamental dimension Equity attribute | ICEPeer $162.81▼-0.63% Cap $91.40BP/E 22.9x QuantScore59/100 | BOLSYLeader $14.30▲+4.87% Cap $23.83BP/E 22.5x QuantScore61/100 | CBOEPeer $340.42▲+3.88% Cap $35.55BP/E 26.5x QuantScore59/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
93/100 |
85/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 77/100 | 68/100 | 52/100 |
Health Piotroski, Altman Z, leverage & liquidity | 38/100 | 50/100 | 77/100 |
Growth Revenue / earnings growth & margins | 42/100 | 43/100 | 44/100 |
Sentiment Analyst ratings, targets & revisions | 46/100 | — | 50/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 22.9x | 22.5x | 26.5x |
Forward P/E (next FY) | 19.9x | 3.8x | 24.2x |
EV / EBITDA (TTM) | 16.6x | 13.4x | 17.0x |
Price / Sales | 7.3x | 11.0x | 7.0x |
Price / Free Cash Flow | 18.9x | 51.0x | 1601.4x |
PEG ratio | 0.65 | 1.35 | 0.53 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 7 / 9 | 5 / 9 |
Altman Z-Score | 0.74 (Distress) | 3.13 (Safe) | 6.14 (Safe) |
Total debt / equity | 0.69 | 0.80 | 0.28 |
Quick ratio | 0.0x | 1.9x | 1.6x |
Interest coverage | 6.9x | 2.8x | 33.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +7.5% | +6.8% | +15.1% |
Net income growth YoY | +20.0% | -1.8% | +43.8% |
Gross margin (TTM) | 79.0% | 79.2% | 52.3% |
Operating margin (FY) | 38.7% | 64.7% | 32.1% |
FCF margin (FY) | 33.9% | 1.6% | 24.5% |
5. Trailing price performancePrice change over period |
1M return | +3.7% | +37.6% | +27.2% |
3M return | +11.6% | +57.7% | +19.4% |
6M return | +2.7% | +26.1% | +12.1% |
Year to date | +0.5% | +80.8% | +35.6% |
1Y return | +3.2% | +106.9% | +42.6% |
3Y return | +52.2% | +105.5% | +109.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $151.18 -7.1% premium | $16.98 +18.8% upside | $245.21 -28.0% premium |
Wall Street consensus target | $183.89 +12.9% · range $160.00–$218.00 | — — | $339.00 -0.4% · range $300.00–$450.00 |
Consensus stance | 86% Buy11% Hold3% Sell | — | 48% Buy42% Hold10% Sell |